3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
67
Breast Neoplasms, Male
4
Neoplasm Metastasis
3
Neoplasms
2
Advanced Breast Cancer
2
Unilateral Breast Neoplasms
1
Sleep Wake Disorders
1
Recurrence
1
Ovarian Neoplasms
1
Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
1
First Line Metastatic Breast Cancer
1
Fatigue
1
Carcinoma, Intraductal, Noninfiltrating
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Carcinoma In Situ
1
Breast Cancer Metastatic
1
Breast Cancer Female
1
Anatomic Stage II Breast Cancer AJCC v8
1
Interventions
Methylphenidate
7
Modafinil
4
Therapeutics
3
Exercise
3
Acupuncture Therapy
3
Surveys and Questionnaires
2
Radiotherapy
2
Counseling
2
Carnitine
2
testosterone enanthate
1
testosterone 17 beta-cypionate
1
exemestane
1
Valeriana extract
1
Triptorelin Pamoate
1
Testosterone
1
Taxes
1
Tamoxifen
1
Sugars
1
Relaxation Therapy
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Psychiatric Rehabilitation
1
Paclitaxel
1
Mental Status and Dementia Tests
1
Materia Medica
1
Infliximab
1
Hypericum extract LI 160
1
Gonadotropin-Releasing Hormone
1
Escitalopram
1
Epoetin Alfa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Fatigue
×
exemestane
×
Clear all
NCT00659373
2016-07-25
Co-SOFT
ETOP IBCSG Partners Foundation
Phase 3
Completed
86 enrolled
4 charts